Dr. Jahan Marcu, PhD
Editor in Chief
American Journal of Endocannabinoid Medicine
Dr. Jahan Marcu, editor in chief if the American Journal of Endocannabinoid Medicine has more than 15 years of experience in cannabis research, policy, and operations. He has been a passionate advocate of consumer safety and the medical benefits of cannabis. He is also among a selected group of professionals globally who has earned PhDs focused on the endocannabinoid system (ECS; with research on the structure and function of cannabinoid receptors, molecular pharmacology of the ECS, and the role of the ECS in bone).
He was the Chief Science Officer and co-founder of the International Research Center on Cannabis and Health, a community-based institute that collaborates with universities, researchers, foundations, state institutions, and others to leverage the highest caliber talent in the field. He is founder and past-chair of the Cannabis Chemistry Subdivision of the American Chemical Society, the world’s largest and oldest professional scientific society. Further illustrating the recognition earned through his efforts, he has been asked to serve on multiple expert government advisory and trade association committees, as well as scientific organizations including ASTM International (D37 Subcommittee chair), American Herbal Products Association (AHPA) Cannabis Committee (past-chair), American Chemical Society Cannabis Chemistry Subdivision, American Oil Chemists’ Society, AOAC International, International Association for Cannabinoid Medicines (past Board of Directors), and the International Medical Cannabis Patient Coalition (co-founder).
Dr. Marcu’s work has been instrumental in facilitating and supporting fact-based, scientific approaches vital to industry and patients. This has included research focused on solving the structure and function of cannabinoid receptors and the anti-cancer properties of cannabis compounds, as well as method development and validation for analyzing complex formulations. Furthermore, his efforts include the development of international certification and training programs, co-authoring American Herbal Pharmacopeia’s Cannabis Quality Control and Therapeutic Monographs, and assisting in the creation of the first standards for industry as a chairman of the cannabis committee for the AHPA.
His dedication to consumer safety is further evident in his work to co-develop a biotech application to predict drug–drug interactions between cannabis and commonly prescribed pharmaceutical drugs (Navigator Genomics). Additionally, Dr. Marcu published one of the first product safety studies on CBD products.
Reflecting his dedication to the field, Dr. Marcu has received numerous awards including the Mahmoud Elsohly Award for Excellence in Cannabis Chemistry and the Billy Martin Research Achievement Award from the International Cannabinoid Research Society for his work on THC and CBD synergy in aggressive brain cancers. He is also a court-qualified synthetic cannabinoid and cannabis expert. His work has been published and covered in publications such as Science, Nature, JAMA, The Washington Post, CNN, and many other media outlets.